THE STUDY
The title could be a bit more clearer..... it's essentially a study and comparison of different refinement schemes from 4 different centres around the UK. The addition of 'The Health Innovation & education cluster(HIEC) glaucoma pathway project' to the title also requires a bit more clarification and expansion within the article. Unfortunately my statistical analysis knowledge is limited, hence I am not commenting on the figures RESULTS & CONCLUSIONS 1. Table 1 shows that almost all the schemes have shown a progressive increase in FVDR( especially post NICE).....except Manchester, which shows a very low FVDR of 3.0 for current practice period. Shouldn't that mean that Manchester's current practice of refining glaucoma referrals seems to be far better than the other schemes? This crucial point seems to have been glossed over in the article....and if you highlight this fact, then the direction of the conclusion and discussion might have to change!! 2. Even though the article mentions about other refinement schemes around the country, the author(s) haven't highlighted the differences( both positives and negatives) between them and the 4 schemes this article deals with.
GENERAL COMMENTS
The issue of false negatives still is an ongoing problem with all the past and present schemes and the authors have rightly acknowledged this. 
RESULTS & CONCLUSIONS
The paper is hard to follow. The introduction is not focused. There is not a clearly defined research question. The design seems to be time series based on retrospective review of data from four sites, each reporting data over three time periods. Inclusion criteria for participants (referrals) are not described. The numbers analysed for each site in each period are not specified in the text or in table 1. %s reported alone are inadequate to interpret the findings.
The analysis is based on the premise that discharge at first visit is a false positive referral. Is this correct? For example if referral was based on IOP > 25mmHg and confirmed by the reference standard provider as OHT, patient could be reasonably discharged to enhanced optometric follow up. This is not a false positive.
Labeling on Figure 2 is unreadable even with zooming.
The limitations of a retrospective observational time series design are not mentioned.
The recommendations are a huge leap from the data presented.
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THE STUDY I have some concerns regarding the clarity of the Methods section. I have highlighted a key paragraph in the attached file and I am finding it, Figure 1 and Table 1 rather confusing. They should all tell a consistent story and I am struggling to find that consistency. In particular, for each scheme it would be very helpful for a statement of who's decision as to discharge or not was the one used to calculate the First Visit Discharge Rate.
Some of the analysis and resulting conclusions are questionable. I have hightlighted these in the attached pdf.
GENERAL COMMENTS
This is a well written paper addressing an important question in an elegant manner. There is a fantastic data set here which deserves to be published. I have some concerns about the clarity of the explanation of the methods, some aspects of the analysis and some of the outcomes. Details have been given in the attached pdf.
There are some typos which have been highlighted in the attached pdf.
VERSION 1 -AUTHOR RESPONSE
Reviewer: Napoleon Devarajan
The title could be a bit more clearer..... it's essentially a study and comparison of different refinement schemes from 4 different centres around the UK. The addition of 'The Health Innovation & education cluster(HIEC) glaucoma pathway project' to the title also requires a bit more clarification and expansion within the article -more description and clarification has been added to the manuscript Unfortunately my statistical analysis knowledge is limited, hence I am not commenting on the figures -acknowledged, no action point required.
1. Table 1 shows that almost all the schemes have shown a progressive increase in FVDR( especially post NICE).....except Manchester, which shows a very low FVDR of 3.0 for current practice period. Shouldn't that mean that Manchester's current practice of refining glaucoma referrals seems to be far better than the other schemes? This crucial point seems to have been glossed over in the article....and if you highlight this fact, then the direction of the conclusion and discussion might have to change!! -The low FVDR of the Manchester scheme has been made more transparent in the discussion.
2. Even though the article mentions about other refinement schemes around the country, the author(s) haven't highlighted the differences( both positives and negatives) between them and the 4 schemes this article deals with. -the appendix describes the scheme. It may be ill advised to discuss subjectively positives and negatives, which the reader can judge for themselves, but rather discuss them in terms of the analysis carried out. Happy to discuss further.
The issue of false negatives still is an ongoing problem with all the past and present schemes and the authors have rightly acknowledged this.
In the Recommendations section, the authours recommend VF and disc examination should be part of referral refinement......but these already exist in other refinement schemes in the country including our local Carmarthenshire Referral refinement scheme. -agreed. The authors' are not saying this is novel finding for referral refinement, simply a recommendation. I know with exception of repeat IOP, disc and VF are included as examination criteria.
Overall, its a well researched study.....just needs a few loose ends tied!
Reviewer: Jennifer Burr
Referencing is poor. The URL links don't work. -this has been checked and all URL's are accurate.
References are out of date-ref 7 -amended, or do not match the text -e.g. references 2,3 -highlighted in comments to editor where in each reference the information was extracted.
Important policy documents are not referenced, e.g. review of eye care services Hawley et al, 2010 (added); Guidance statements from the relevant colleges are quoted verbatim rather than the essence summarised. Recent commissioning guidance by the Colleges (Ophthalmology and Optometry) is not mentioned (although this may have been after the paper was submitted) are not described -this was published after the paper was submitted but have now added
Participants in each of the sites are not described -demographic details added Statistical methods are given a name but are not well described or justified -amended. \ It is not an easy read. There are many typographical and style errors. For example 'non-OSI referrals'. This is repeated many times with reference to optometrists with a specialist interest and those without. It could be interpreted as no referral. Many abbreviations and ophthalmology specialist terms used without explanation of their value. -non-OSI referrals changed to 'referrals from non-OSIs'
The paper is hard to follow. The introduction is not focused -I agree but in comments to reviewer section, I explained that as this is not a specialist ophthalmic journal, more background information is warranted even if it leads to a less focused introduction. This had been checked by a general clinician and non-clinician prior to submitting and they were both able to follow the introduction. Happy to discuss further.
There is not a clearly defined research question -see article focus question one
The design seems to be time series based on retrospective review of data from four sites, each reporting data over three time periods. Inclusion criteria for participants (referrals) are not describedadded to manuscript as well as exclusion criteria.
The numbers analysed for each site in each period are not specified in the text or in table 1. %s reported alone are inadequate to interpret the findings -added to manuscript in the text.
The analysis is based on the premise that discharge at first visit is a false positive referral. Is this correct? For example if referral was based on IOP > 25mmHg and confirmed by the reference standard provider as OHT, patient could be reasonably discharged to enhanced optometric follow up. This is not a false positive -completely agree and this is why we chose FVDR as our outcome metric to not imply correctness or falseness or referral. I have made this more explicit in the methods section of the manuscript.
Labeling on Figure 2 is unreadable even with zooming -resolution and layout improved.
The limitations of a retrospective observational time series design are not mentioned -added
The recommendations are a huge leap from the data presented -with revised manuscript hopefully this is no longer the case. Happy to discuss.
Ethical approval is not mentioned -see methods
Reviewer: David F Edgar I have some concerns regarding the clarity of the Methods section. I have highlighted a key paragraph in the attached file and I am finding it, Figure 1 and Table 1 rather confusing. They should all tell a consistent story and I am struggling to find that consistency. In particular, for each scheme it would be very helpful for a statement of who's decision as to discharge or not was the one used to calculate the First Visit Discharge Rate.
This is a well written paper addressing an important question in an elegant manner. There is a fantastic data set here which deserves to be published. I have some concerns about the clarity of the explanation of the methods, some aspects of the analysis and some of the outcomes. Details have been given in the attached pdf. There are some typos which have been highlighted in the attached pdf
All of David's queries/comments from the PDF have been amended in the tracked changed manuscript with a comment saying something along the lines of 'in response to reviewer 3 comment'.
